DILANTIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dilantin, and what generic alternatives are available?
Dilantin is a drug marketed by Viatris, Parke Davis, and Pharmacia. and is included in four NDAs.
The generic ingredient in DILANTIN is phenytoin. There are twenty-one drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the phenytoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dilantin
A generic version of DILANTIN was approved as phenytoin by TARO on March 8th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DILANTIN?
- What are the global sales for DILANTIN?
- What is Average Wholesale Price for DILANTIN?
Summary for DILANTIN
US Patents: | 0 |
Applicants: | 3 |
NDAs: | 4 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 155 |
Clinical Trials: | 23 |
Patent Applications: | 1,699 |
Drug Prices: | Drug price information for DILANTIN |
Drug Sales Revenues: | Drug sales revenues for DILANTIN |
DailyMed Link: | DILANTIN at DailyMed |
Recent Clinical Trials for DILANTIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Bristol-Myers Squibb | Phase 1 |
Lawson Health Research Institute | Phase 4 |
UCB Pharma GmbH | Phase 4 |
Pharmacology for DILANTIN
US Patents and Regulatory Information for DILANTIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Viatris | DILANTIN | phenytoin sodium | CAPSULE;ORAL | 084349-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharmacia | DILANTIN | phenytoin | TABLET, CHEWABLE;ORAL | 084427-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Viatris | DILANTIN | phenytoin sodium | CAPSULE;ORAL | 084349-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |